Who Paid My Doc
Embotrap
Device Neurovascular
PDI 10886704081326
General payments
$1,122,729
Research payments
$6,140,136
Through program year 2025, $1,122,729 in general payments and $6,140,136 in research payments were reported against Embotrap (Neurovascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $307,849 | 41 |
| 2025 | Research | $1,175,819 | 45 |
| 2024 | General | $280,303 | 23 |
| 2024 | Research | $1,966,696 | 118 |
| 2023 | General | $156,129 | 90 |
| 2023 | Research | $1,136,026 | 112 |
| 2022 | General | $192,413 | 157 |
| 2022 | Research | $1,066,630 | 31 |
| 2021 | General | $186,035 | 731 |
| 2021 | Research | $794,964 | 165 |
Breakdown
The top 5 of 19 recipients; each share is of general payments naming this product in 2025.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 12 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,042 general · 471 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.